Gustave Roussy, Cancer Campus, Grand Paris: Neoplasms trials
The registry lists 18 Neoplasms studies with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 5Phase 3 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine TumorNot yet recruitingNCT07471425
- PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave RoussyRecruitingNCT06479057
- Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young AdultsRecruitingNCT04477681
- Neurocognitive Risks in Children With Solid TumorsRecruitingNCT03609112
- European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsRecruitingNCT02813135Phase 1/2
- Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant PembrolizumabWithdrawnNCT06116578Phase 2
- Optimization of an Online Stepwise Therapeutic Device Based on a Cognitive-behavioral Approach for Cancer Patients With InsomniaCompletedNCT05977062Not applicable
- Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced CancersTerminatedNCT04270864Phase 1
- Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory DrugsActive, not recruitingNCT03984318Not applicable
- A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate CancerCompletedNCT03314324Phase 2
- Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic CancerStatus unknownNCT02666612Not applicable
- Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular ProfilingCompletedNCT02613962Not applicable
- Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer TherapiesCompletedNCT02517281Not applicable
- Transpulmonary Thermodilution Using an Implented Central Venous Access PortCompletedNCT02357953
- Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and AdolescentsCompletedNCT00412503Phase 1
- Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal ChemohyperthermiaTerminatedNCT00180960Phase 2
- Unmodified Versus Leuko-reduced Allogeneic Red Blood Cells Transfusion in Cancer PatientsCompletedNCT00180869Phase 3
- High Risk Primitive Neuroectodermal (PNET) Brain Tumors in ChildhoodStatus unknownNCT00180791Phase 2